[Lung carcinoma. An unusual case of survival].
Lung cancer incidence is continuously increasing over the world, despite significant advances in both the diagnostic and therapeutic fields. At the diagnosis, more than 2/3 of patients present a locally advanced disease associated with a 5-year survival of less than 35%, or with distant metastases associated with no long-time survival. Chemotherapy with cisplatin remains a well established option in the treatment of lung cancer, as confirmed by recent meta-analyses, and its action seems strengthened by the introduction of new agents (taxans, gemcitabine, vinorelbine, topotecan, and others), that are giving promising results for a better control of this disease.
Della Vittoria Scarpati
Michele
M
Dipartimento di Scienze Cardio-Toraciche e Respiratorie, Cattedra di Chirurgia Toracica, II Università, Napoli. mdvs.t@tin.it
Vicidomini
Giovanni
G
Della Vittoria Scarpati
Giuseppina
G
Santini
Mario
M
D000230:Adenocarcinoma / Q000628:therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D017741:Survivors
Carcinoma del polmone. Un caso non comune di sopravvivenza.